INCR
INC Research Holdings Inc
NASDAQ: INCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.81
-6.38% today
Updated 2026-04-29
Market cap
$49.15M
P/E ratio
—
P/S ratio
0.55x
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $2
Volume
0.0M
INC Research Holdings Inc (INCR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.81
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.2B | $0.4B | $0.4B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -29.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.